Articolul precedent |
Articolul urmator |
77 0 |
Căutarea după subiecte similare conform CZU |
616.153.922-053.2 (1) |
Patologia sistemului circulator, a vaselor sanguine. Tulburări cardiovasculare (975) |
SM ISO690:2012 EŞANU, Veronica, EŞANU, Valeriu, PÎRŢU, Lucia, PALII, Ina. Importanța identificării, diagnosticul și tratamentul hipercolesterolemiei familiale heterozigote în rândul populației pediatrice. In: Tranziția copilului cu maladii cronice la viața de adult, Ed. Ediția a VI-a, 26-27 mai 2023, Chişinău. Chişinău: Taicom (Ridgeone Group), 2023, Ediția a VI-a, pp. 53-57. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Tranziția copilului cu maladii cronice la viața de adult Ediția a VI-a, 2023 |
||||||
Conferința "Tranziția copilului cu maladii cronice la viața de adult" Ediția a VI-a, Chişinău, Moldova, 26-27 mai 2023 | ||||||
|
||||||
CZU: 616.153.922-053.2 | ||||||
Pag. 53-57 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Heterozygous familial hypercholesterolemia (HeFH) is a frequent, autosomal dominant clinical entity (1:220 people worldwide), characterized by an increase in the level of low molecular density lipoproteins (LDL-C), throughout life and which, in the absence of treatment accelerates the onset of atherosclerosis, increasing the risk of cardiovascular events. The most common causes are pathogenic variants (mutations) of the LDL receptor (LDL-R) gene, which are responsible for 85% - 90% of genetically confirmed ones, of the apolipoprotein B (ApoB) gene, which result in decreased binding of LDL to receptor (LDL-R), or of the proprotein convertase subtilisin/kexin 9 (PCSK9) gene, which causes increased destruction of LDL-R, being responsible for 5% - 15% and 1% of cases, respectively. It is crucial to consider the diagnosis of HeHF, in children with LDL-C >160 mg/dL (4.1 mmol/L, persistent!), in adults with LDL-C >190 mg/ dL (4.9 mmol /L) (especially if there is a family history of early CVD) and in all those with early CVD. HeHF is significantly underdiagnosed and undertreated, especially in the pediatric population. The burden of early diagnosis remains on the shoulders of pediatricians, who hold a unique potential to facilitate improved detection and management of this pathology, at least until adulthood. |
||||||
Cuvinte-cheie heterozygous familial hypercholesterolemia, children, семейная гетерозиготная гиперхолестеринемия, дети |
||||||
|